Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 26 studies | 36% ± 18% | |
pericyte | 24 studies | 39% ± 17% | |
ciliated cell | 19 studies | 58% ± 24% | |
smooth muscle cell | 18 studies | 32% ± 14% | |
fibroblast | 18 studies | 34% ± 18% | |
basal cell | 17 studies | 59% ± 21% | |
epithelial cell | 13 studies | 50% ± 20% | |
vein endothelial cell | 11 studies | 35% ± 18% | |
goblet cell | 9 studies | 29% ± 12% | |
endothelial cell of artery | 8 studies | 42% ± 23% | |
endothelial cell of vascular tree | 8 studies | 30% ± 9% | |
secretory cell | 7 studies | 47% ± 21% | |
connective tissue cell | 7 studies | 46% ± 28% | |
transit amplifying cell | 7 studies | 30% ± 6% | |
club cell | 6 studies | 33% ± 18% | |
hepatocyte | 6 studies | 48% ± 21% | |
abnormal cell | 6 studies | 51% ± 19% | |
mesothelial cell | 6 studies | 73% ± 16% | |
capillary endothelial cell | 6 studies | 44% ± 19% | |
macrophage | 5 studies | 19% ± 3% | |
enteroendocrine cell | 5 studies | 45% ± 18% | |
brush cell | 5 studies | 50% ± 26% | |
neuron | 5 studies | 44% ± 19% | |
pancreatic A cell | 4 studies | 32% ± 12% | |
podocyte | 4 studies | 47% ± 28% | |
myofibroblast cell | 4 studies | 28% ± 14% | |
progenitor cell | 4 studies | 52% ± 23% | |
deuterosomal cell | 3 studies | 37% ± 8% | |
respiratory goblet cell | 3 studies | 24% ± 4% | |
intestinal crypt stem cell | 3 studies | 32% ± 7% | |
neural crest cell | 3 studies | 64% ± 13% | |
kidney loop of Henle epithelial cell | 3 studies | 33% ± 9% | |
neuroendocrine cell | 3 studies | 60% ± 27% | |
astrocyte | 3 studies | 46% ± 12% | |
myoepithelial cell | 3 studies | 60% ± 32% | |
mature NK T cell | 3 studies | 18% ± 3% | |
natural killer cell | 3 studies | 26% ± 10% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
ovary | 99% | 13030.11 | 179 / 180 | 99% | 604.15 | 426 / 430 |
prostate | 100% | 10602.11 | 245 / 245 | 98% | 227.60 | 493 / 502 |
breast | 98% | 4527.54 | 448 / 459 | 70% | 110.79 | 781 / 1118 |
liver | 96% | 15121.37 | 218 / 226 | 70% | 264.38 | 286 / 406 |
pancreas | 100% | 9202.58 | 328 / 328 | 61% | 89.62 | 109 / 178 |
stomach | 100% | 16624.82 | 359 / 359 | 60% | 110.31 | 173 / 286 |
esophagus | 100% | 6827.50 | 1442 / 1445 | 60% | 104.21 | 110 / 183 |
lung | 84% | 3273.28 | 487 / 578 | 67% | 294.98 | 779 / 1155 |
uterus | 95% | 7147.44 | 162 / 170 | 53% | 184.81 | 241 / 459 |
intestine | 61% | 2072.09 | 591 / 966 | 68% | 131.38 | 359 / 527 |
bladder | 81% | 6063.86 | 17 / 21 | 39% | 86.30 | 195 / 504 |
adrenal gland | 74% | 2417.32 | 191 / 258 | 40% | 90.75 | 91 / 230 |
thymus | 87% | 2844.37 | 567 / 653 | 23% | 58.90 | 141 / 605 |
kidney | 99% | 7474.37 | 88 / 89 | 8% | 11.95 | 69 / 901 |
spleen | 100% | 18896.26 | 241 / 241 | 0% | 0 | 0 / 0 |
blood vessel | 97% | 30812.69 | 1296 / 1335 | 0% | 0 | 0 / 0 |
adipose | 97% | 6480.40 | 1168 / 1204 | 0% | 0 | 0 / 0 |
heart | 86% | 4985.96 | 737 / 861 | 0% | 0 | 0 / 0 |
skin | 38% | 1317.31 | 689 / 1809 | 40% | 104.85 | 190 / 472 |
tonsil | 0% | 0 | 0 / 0 | 73% | 239.08 | 33 / 45 |
brain | 5% | 85.70 | 119 / 2642 | 36% | 136.48 | 254 / 705 |
eye | 0% | 0 | 0 / 0 | 38% | 37.65 | 30 / 80 |
lymph node | 0% | 0 | 0 / 0 | 7% | 5.54 | 2 / 29 |
muscle | 5% | 97.08 | 41 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 2% | 64.68 | 20 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0007584 | Biological process | response to nutrient |
GO_0032355 | Biological process | response to estradiol |
GO_0042104 | Biological process | positive regulation of activated T cell proliferation |
GO_0043627 | Biological process | response to estrogen |
GO_0032870 | Biological process | cellular response to hormone stimulus |
GO_0007565 | Biological process | female pregnancy |
GO_0090090 | Biological process | negative regulation of canonical Wnt signaling pathway |
GO_0051384 | Biological process | response to glucocorticoid |
GO_0032526 | Biological process | response to retinoic acid |
GO_0009612 | Biological process | response to mechanical stimulus |
GO_0009410 | Biological process | response to xenobiotic stimulus |
GO_0043567 | Biological process | regulation of insulin-like growth factor receptor signaling pathway |
GO_0016324 | Cellular component | apical plasma membrane |
GO_0005615 | Cellular component | extracellular space |
GO_0005576 | Cellular component | extracellular region |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005102 | Molecular function | signaling receptor binding |
GO_0031994 | Molecular function | insulin-like growth factor I binding |
GO_0031995 | Molecular function | insulin-like growth factor II binding |
GO_0005515 | Molecular function | protein binding |
Gene name | IGFBP2 |
Protein name | Insulin like growth factor binding protein 2 Insulin-like growth factor-binding protein 2 Insulin-like growth factor-binding protein 2 (IBP-2) (IGF-binding protein 2) (IGFBP-2) |
Synonyms | IBP2 BP2 |
Description | FUNCTION: Inhibits IGF-mediated growth and developmental rates. IGF-binding proteins prolong the half-life of the IGFs and have been shown to either inhibit or stimulate the growth promoting effects of the IGFs on cell culture. They alter the interaction of IGFs with their cell surface receptors. . |
Accessions | ENST00000434997.1 P18065 ENST00000436812.1 C9JMY1 ENST00000456764.1 C9JW52 ENST00000233809.9 H7C1H0 |